Literature DB >> 1690755

Disease-associated human histocompatibility leukocyte antigen determinants in patients with seropositive rheumatoid arthritis. Functional role in antigen-specific and allogeneic T cell recognition.

C M Weyand1, J J Goronzy.   

Abstract

The susceptibility to develop seropositive rheumatoid arthritis (RA) has been linked to specific genomic polymorphisms within the HLA complex. Two different haplotypes have been associated with the disease, HLA-DR1 and HLA-DR4. To investigate the link between such phenotypic disease associations and potential immune mechanisms we used alloreactive and antigen-specific human T cell clones. Here we describe a panel of alloreactive T cell clones directed to polymorphic determinants encoded by the third hypervariable region (hvr) of the HLA-DR beta 1-chain. T cell determinants defined by these clones are shared among HLA-DR1, HLA-Dw4, HLA-Dw13, HLA-Dw14, and HLA-Dw15, and are frequent in a population of RA patients. To study the role of such disease-associated epitopes in antigen-restricted T cell recognition we generated T cell clones from RA patients specific for mycobacterial antigens, Epstein-Barr virus antigens, and tetanus toxoid. In all three antigenic systems T cell clones were restricted to either HLA-DR1 or HLA-DR4. These data suggest that the polymorphisms within the first and second hvr of the HLA-DR beta 1-chain that are distinct in HLA-DR1 and HLA-DR4 and not associated with the disease are crucially involved in the recognition of antigens. Polymorphic determinants encoded by the third hvr are shared among disease-associated haplotypes and may function to mediate the interaction of alloreactive T cell receptor molecules with the HLA complex.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690755      PMCID: PMC296534          DOI: 10.1172/JCI114535

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Evidence for an HLA-DR4-associated immune-response gene for Mycobacterium tuberculosis. A clue to the pathogenesis of rheumatoid arthritis?

Authors:  T H Ottenhoff; P Torres; J T de las Aguas; R Fernandez; W van Eden; R R de Vries; J L Stanford
Journal:  Lancet       Date:  1986-08-09       Impact factor: 79.321

2.  A mouse monoclonal antibody against a polymorphic determinant in a defined subset of DR molecules.

Authors:  M C Mazzilli; N Tanigaki; I Cascino; S Costanzi Porrini; S Trabace; S Cappellacci; L Testa; E Gandini
Journal:  Hum Immunol       Date:  1986-06       Impact factor: 2.850

3.  Mapping of allospecific T-cell recognition sites encoded by the HLA-DR4 beta 1-chain.

Authors:  C M Weyand; J J Goronzy
Journal:  Hum Immunol       Date:  1989-02       Impact factor: 2.850

4.  Cloning of human alloreactive T cells.

Authors:  J Goronzy; C Weyand; C G Fathman
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  T cells can distinguish between allogeneic major histocompatibility complex products on different cell types.

Authors:  P Marrack; J Kappler
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

6.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

7.  Human T-cell clones used to define functional epitopes on HLA class II molecules.

Authors:  C M Weyand; J Goronzy; C G Fathman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

8.  Shared T cell recognition sites on human histocompatibility leukocyte antigen class II molecules of patients with seropositive rheumatoid arthritis.

Authors:  J Goronzy; C M Weyand; C G Fathman
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

9.  HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes.

Authors:  G T Nepom; P Byers; C Seyfried; L A Healey; K R Wilske; D Stage; B S Nepom
Journal:  Arthritis Rheum       Date:  1989-01

10.  HLA antigen associations with extra-articular rheumatoid arthritis.

Authors:  W Ollier; P J Venables; P A Mumford; R N Maini; J Awad; D Jaraquemada; J D'Amaro; H Festenstein
Journal:  Tissue Antigens       Date:  1984-11
View more
  7 in total

1.  Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells.

Authors:  B Ong; N Willcox; P Wordsworth; D Beeson; A Vincent; D Altmann; J S Lanchbury; G C Harcourt; J I Bell; J Newsom-Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

2.  Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis.

Authors:  C M Weyand; C Xie; J J Goronzy
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

3.  Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis.

Authors:  J J Goronzy; P Bartz-Bazzanella; W Hu; M C Jendro; D R Walser-Kuntz; C M Weyand
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

4.  Selective induction of rheumatoid factors by superantigens and human helper T cells.

Authors:  X W He; J Goronzy; C Weyand
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

5.  Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis.

Authors:  C M Weyand; T G McCarthy; J J Goronzy
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 6.  New insights into the impact of neuro-inflammation in rheumatoid arthritis.

Authors:  Nicholas R Fuggle; Franklyn A Howe; Rachel L Allen; Nidhi Sofat
Journal:  Front Neurosci       Date:  2014-11-06       Impact factor: 4.677

7.  Interaction between extracellular matrix molecules and microbial pathogens: evidence for the missing link in autoimmunity with rheumatoid arthritis as a disease model.

Authors:  Nidhi Sofat; Robin Wait; Saralili D Robertson; Deborah L Baines; Emma H Baker
Journal:  Front Microbiol       Date:  2015-01-14       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.